2. Academic Validation
  3. MiR-375 inhibits the stemness of breast cancer cells by blocking the JAK2/STAT3 signaling

MiR-375 inhibits the stemness of breast cancer cells by blocking the JAK2/STAT3 signaling

  • Eur J Pharmacol. 2020 Oct 5;884:173359. doi: 10.1016/j.ejphar.2020.173359.
Qiong Zhao 1,  Yichen Liu 1,  Ting Wang 1,  Yue Yang 1,  Haiwei Ni 1,  Hai Liu 1,  Qianqian Guo 2,  Tao Xi 3,  Lufeng Zheng 4
Affiliations

Affiliations

  • 1 School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Longmian Road 639, Nanjing, 211198, PR China.
  • 2 Department of Pharmacy, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 127 Dongming Road, Zhengzhou, 450003, PR China.
  • 3 School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Longmian Road 639, Nanjing, 211198, PR China. Electronic address: Xitao18@hotmail.com.
  • 4 School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Longmian Road 639, Nanjing, 211198, PR China. Electronic address: zhlf@cpu.edu.cn.
PMID: 32738343 DOI: 10.1016/j.ejphar.2020.173359
Abstract

The relapse of breast Cancer could be due to the existence of breast Cancer Stem Cells (BCSCs). Other and our researches have indicated the suppressive roles of miR-375 in various tumors, however, its roles in breast Cancer stemness remain confusing. Here, we constructed breast Cancer cells with miR-375 stable overexpression via lentivirus Infection. Flow cytometry, Western blot, mammosphere formation, cell colony formation and CCK8 as well as in vivo assays were performed to identify the role of miR-375 in the stemness of breast Cancer cells. Luciferase reporter, RNA-Fluorescence in situ hybridization (RNA-FISH) and RNA-binding protein immunoprecipitation (RIP) assays were utilized to elucidate the mechanism whereby miR-375 exerts its effects. It was found that miR-375 not only reduced the stemness, but also decreased adriamycin resistance of breast Cancer cells. These results were characterized by the decrease of BCSC rate, mammosphere-forming and tumor-initiating ability, and IC50 value of adriamycin, and weakened by JAK2 re-expression. This work indicates that miR-375 suppresses the stemness of breast Cancer cells through targeting JAK2.

Keywords

Adriamycin resistance; Cancer stem cells; JAK2/STAT3; miR-375.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z